These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 22415097)

  • 1. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
    Dai XY; Zeng XX; Peng F; Han YY; Lin HJ; Xu YZ; Zhou T; Xie G; Deng Y; Mao YQ; Yu LT; Yang L; Zhao YL
    Cell Physiol Biochem; 2012; 29(1-2):281-90. PubMed ID: 22415097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKLB70326, a novel small-molecule inhibitor of cell-cycle progression, induces G₀/G₁ phase arrest and apoptosis in human hepatic carcinoma cells.
    Han Y; He H; Peng F; Liu J; Dai X; Lin H; Xu Y; Zhou T; Mao Y; Xie G; Yang S; Yu L; Yang L; Zhao Y
    Biochem Biophys Res Commun; 2012 May; 421(4):684-9. PubMed ID: 22542944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells.
    Gao X; Han L; Ding N; Mu Y; Guan P; Hu C; Huang X
    J Antibiot (Tokyo); 2018 Sep; 71(9):808-817. PubMed ID: 29752478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.
    Baek SY; Hwang UW; Suk HY; Kim YW
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32375410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticancer activity of the substituted pyridone-annelated isoindigo (5'-Cl) involves G0/G1 cell cycle arrest and inactivation of CDKs in the promyelocytic leukemia cell line HL-60.
    Saleh AM; Aljada A; El-Abadelah MM; Taha MO; Sabri SS; Zahra JA; Aziz MA
    Cell Physiol Biochem; 2015; 35(5):1943-57. PubMed ID: 25870953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G(0) /G(1) cell cycle arrest and apoptosis.
    Kan WL; Yin C; Xu HX; Xu G; To KK; Cho CH; Rudd JA; Lin G
    Int J Cancer; 2013 Feb; 132(3):707-16. PubMed ID: 22733377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
    Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
    Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
    Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
    Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
    Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
    Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.
    Zhao H; Zhang Y; Sun J; Zhan C; Zhao L
    Oncol Res; 2016; 23(5):237-48. PubMed ID: 27098147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
    Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
    Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
    Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
    Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
    Qin Y; Pan X; Tang TT; Zhou L; Gong XG
    Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL299, a Benzimidazole Derivative Induces G
    Ohno Y; Yi R; Suganami A; Tamura Y; Matsumoto A; Matsumoto S; Saito K; Shirasawa H
    Anticancer Res; 2021 Feb; 41(2):699-706. PubMed ID: 33517274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2.
    Bi W; Xiao JC; Liu RJ; Zhou LY; Zhang S; Yang M; Zhang PF
    Invest New Drugs; 2020 Apr; 38(2):287-298. PubMed ID: 31076964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of di-n-butyl-(2,6-difluorobenzohydroxamato)tin(IV) against human gastric carcinoma SGC-7901 cells via G2/M cell cycle arrest and cell apoptosis.
    Yunlan L; Juan Z; Qingshan L
    PLoS One; 2014; 9(3):e90793. PubMed ID: 24643073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.